Bulletin
Investor Alert

Mesoblast Ltd. ADR

NAS: MESO

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Mesoblast Ltd. ADR

After Hours

MESO
/zigman2/quotes/209376591/composite

$

9.59

Change

-0.04 -1.34%

Volume

Volume 7,112

Jan 15, 2021, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209376591/composite

Previous close

$ 9.83

$ 9.72

Change

-0.11 -1.12%

Day low

Day high

$9.58

$10.36

Open
Open: 10.32

52 week low

52 week high

$3.12

$21.28

Open

Market cap

$1.10B

Average volume

895,204

P/E ratio

N/A

Rev. per Employee

$309,732

EPS

-0.87

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/meso

MarketWatch News on MESO

  1. Why Brinker International Shares Look Tasty

    8:30 p.m. Oct. 16, 2020

    - Barron's Online

  2. Mesoblast stock price target raised to $22 from $16 at Maxim Group

    6:25 a.m. Aug. 14, 2020

    - Tomi Kilgore

  3. Mesoblast stock price target raised to $15.25 from $13.00 at Ladenburg Thalmann

    6:56 a.m. May 28, 2020

    - Tomi Kilgore

  5. Four Biotech Picks for Cures Law

    4:20 p.m. Jan. 26, 2017

    - Barron's Online

  6. Mesoblast May Have an Edge on Pluristem

    4:09 p.m. Dec. 29, 2016

    - Barron's Online

  7. Mesoblast downgraded to neutral from outperform at Credit Suisse

    7:25 a.m. June 14, 2016

    - Tomi Kilgore

  8. Mesoblast stock price target cut to $5 from $10 at Credit Suisse

    7:25 a.m. June 14, 2016

    - Tomi Kilgore

  9. Mesoblast downgraded to neutral from overweight at J.P. Morgan

    7:41 a.m. March 7, 2016

    - Tomi Kilgore

  10. 10 Biotech Buys from Credit Suisse

    11:45 a.m. Jan. 20, 2016

    - Barrons Blogs

  11. Mesoblast started at outperform with $10 stock price target at Credit Suisse

    8:19 a.m. Jan. 20, 2016

    - Tomi Kilgore

  13. Osiris stem-cell therapy wins Canadian approval

    4:42 p.m. May 17, 2012

    - Val Brickates Kennedy

  14. Are stem-cell stocks a good buy?

    2:05 p.m. July 13, 2011

    - Val Brickates Kennedy

  15. Amylin and Alkermes shine in drug-stocks trading

    2:07 p.m. July 8, 2011

    - Val Brickates Kennedy

  16. Stem-cell stocks rise on artificial-trachea report

    1:56 p.m. July 8, 2011

    - Val Brickates Kennedy

Analyst Ratings

/news/nonmarketwatch/company/us/meso

Other News on MESO

  1. Company News for Jan 12, 2021

    9:32 a.m. Jan. 12, 2021

    - Zacks.com

  3. Lemonade, Mesoblast leads the premarket losers' pack

    8:32 a.m. Jan. 12, 2021

    - Seeking Alpha

  4. TRXC, WATT, EDIT and RIOT among midday movers

    12:41 p.m. Jan. 11, 2021

    - Seeking Alpha

  5. LLY, GME, NIO and BNGO among notable premarket gainers

    8:28 a.m. Jan. 11, 2021

    - Seeking Alpha

  6. Mesoblast's rexlemestrocel-l reduces heart attacks, strokes

    11:47 p.m. Jan. 10, 2021

    - Seeking Alpha

  8. Wall Street Breakfast: What Moved Markets

    9:15 a.m. Dec. 26, 2020

    - Seeking Alpha

  9. Mesoblast: The Future Looks Bleak

    3:01 a.m. Dec. 24, 2020

    - Seeking Alpha

  10. Wall Street Breakfast: What Moved Markets

    9:30 a.m. Dec. 19, 2020

    - Seeking Alpha

  11. ONVO, UAVS, MESO and APDN among midday movers

    12:39 p.m. Dec. 18, 2020

    - Seeking Alpha

  13. MVIS, PGEN, SLDB and AMWL among midday movers

    12:40 p.m. Dec. 15, 2020

    - Seeking Alpha

  19. ACB, BB, TLRY and BNTX among premarket gainers

    8:22 a.m. Dec. 2, 2020

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/meso

Press Releases on MESO

  13. Mesoblast Webcast - Update on COVID-19 ARDS Trial

    10:07 p.m. Dec. 17, 2020

    - GlobeNewswire

  14. Mesoblast Update on COVID-19 ARDS Trial

    6:31 p.m. Dec. 17, 2020

    - GlobeNewswire

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.